Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences
Authors:
- Theresa KagermeierTKTheresa Kagermeier
- Stefan HauserSHStefan Hauser
- Kseniia SarievaKSKseniia Sarieva
- Lucia LaugwitzLLLucia Laugwitz
- Samuel GroeschelSGSamuel Groeschel
- Wibke G. JanzarikWJWibke G. Janzarik
- Zeynep YentürZYZeynep Yentür
- Katharina BeckerKBKatharina Becker
- Ludger SchölsLudger Schöls
- Ingeborg Krägeloh-MannIngeborg Krägeloh-Mann
- Simone MayerSMSimone Mayer
Open Access
- 1 July 2024
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 17 (7)
Abstract
Pontocerebellar hypoplasia type 2a (PCH2a) is an ultra-rare, autosomal recessive pediatric disorder with limited treatment options. Its anatomical hallmark is hypoplasia of the cerebellum and pons accompanied by progressive microcephaly. A homozygous founder variant in TSEN54, which encodes a tRNA splicing endonuclease (TSEN) complex subunit, is causal. The pathological mechanism of PCH2a remains unknown due to the lack of a model system. Therefore, we developed human models of PCH2a using regionalized neural organoids. We generated induced pluripotent stem cell (iPSC) lines from three males with genetically confirmed PCH2a and subsequently differentiated cerebellar and neocortical organoids. Mirroring clinical neuroimaging findings, PCH2a cerebellar organoids were reduced in size compared to controls starting early in differentiation. Neocortical PCH2a organoids demonstrated milder growth deficits. Although PCH2a cerebellar organoids did not upregulate apoptosis, their stem cell zones showed altered proliferation kinetics, with increased proliferation at day 30 and reduced proliferation at day 50 compared to controls. In summary, we generated a human model of PCH2a, providing the foundation for deciphering brain region-specific disease mechanisms. Our first analyses suggest a neurodevelopmental aspect of PCH2a.Keywords
All Related Versions
Funding Information
- PCH-Familie e.V.
- Gemeinnützige Hertie-Stiftung
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
- Heidelberger Akademie der Wissenschaften
- Chan Zuckerberg Initiative (2022-316727)
- Silicon Valley Community Foundation
- Eberhard Karls Universität Tübingen
This publication has 73 references indexed in Scilit:
- Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiationThe American Journal of Human Genetics, 2022
- Human organoids to model the developing human neocortex in health and diseaseBrain Research, 2020
- Three-dimensional microCT imaging of murine embryonic development from immediate post-implantation to organogenesis: application for phenotyping analysis of early embryonic lethality in mutant animalsMammalian Genome, 2017
- Consensus Paper: Cerebellar DevelopmentThe Cerebellum, 2015
- A Dual Program for Translation Regulation in Cellular Proliferation and DifferentiationCell, 2014
- Pontocerebellar hypoplasiaAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2014
- An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood CellsStem Cells, 2013
- Neuronal scaling rules for primate brains2012
- Pontocerebellar hypoplasia type 2: a neuropathological updateActa Neuropathologica, 2007
- Severe, fetal‐onset form of olivopontocerebellar hypoplasia in three sibs: PCH type 5?American Journal of Medical Genetics Part A, 2006